Scarica l'app Stockscreener
2.45
2.51%
0.06
Dopo l'orario di chiusura:
2.45
Precedente Chiudi:
$2.39
Aprire:
$2.43
Volume 24 ore:
374.28K
Relative Volume:
1.24
Capitalizzazione di mercato:
$257.77M
Reddito:
$7.05M
Utile/perdita netta:
$-30.43M
Rapporto P/E:
-6.4678
EPS:
-0.3788
Flusso di cassa netto:
$21.84M
1 W Prestazione:
+8.89%
1M Prestazione:
+15.84%
6M Prestazione:
+20.10%
1 anno Prestazione:
+29.97%
Intervallo 1D:
$2.36
$2.50
Intervallo di 1 settimana:
$2.22
$2.50
Portata 52W:
$1.07
$4.62
Proqr Therapeutics N V Stock (PRQR) Company Profile
Nome
Proqr Therapeutics N V
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PRQR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.45 | 251.77M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-04-29 | Iniziato | Evercore ISI | Outperform |
| 2025-03-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-29 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | Downgrade | Stifel | Buy → Hold |
| 2022-02-01 | Iniziato | Raymond James | Strong Buy |
| 2021-05-03 | Iniziato | Stifel | Buy |
| 2021-03-25 | Reiterato | Citigroup | Buy |
| 2020-11-03 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-03-12 | Reiterato | Chardan Capital Markets | Buy |
| 2018-12-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-11-15 | Iniziato | Citigroup | Buy |
| 2018-09-19 | Iniziato | Evercore ISI | Outperform |
| 2017-09-26 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-06-20 | Iniziato | Chardan Capital Markets | Neutral |
| 2014-10-15 | Iniziato | Deutsche Bank | Buy |
| 2014-10-13 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Proqr Therapeutics N V Borsa (PRQR) Ultime notizie
Building trade automation scripts for ProQR Therapeutics N.V.2025 Bull vs Bear & Smart Money Movement Alerts - Newser
What high frequency data says about ProQR Therapeutics N.V.2025 Historical Comparison & Entry Point Strategy Guides - Newser
Will ProQR Therapeutics N.V. price bounce be sustainableQuarterly Profit Summary & Weekly Watchlist of Top Performers - Newser
Custom strategy builders for tracking ProQR Therapeutics N.V.Trend Reversal & Free Reliable Trade Execution Plans - Newser
Can trapped investors hope for a rebound in ProQR Therapeutics N.V.Weekly Risk Summary & Community Verified Trade Signals - Newser
Can technical indicators confirm ProQR Therapeutics N.V.’s reversal2025 Price Targets & AI Enhanced Trading Signals - Newser
ProQR Therapeutics: Not A Needle Mover Just Yet - Seeking Alpha
What is ProQR Therapeutics N.V.’s book value per shareProfit Target & Safe Swing Trade Setup Alerts - خودرو بانک
Intraday pattern recognizer results for ProQR Therapeutics N.V.Analyst Downgrade & Smart Allocation Stock Tips - Newser
What are ProQR Therapeutics N.V.’s recent SEC filings showingJuly 2025 Decliners & Verified Entry Point Detection - خودرو بانک
What to expect from ProQR Therapeutics N.V. in the next 30 daysQuarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Can ProQR Therapeutics N.V. generate free cash flowProduct Launch & Free Expert Verified Stock Movement Alerts - خودرو بانک
Sentiment Recap: What is the target price for ProQR Therapeutics N.V. stockRate Cut & Stepwise Trade Signal Implementation - خودرو بانک
Is ProQR Therapeutics N.V. meeting your algorithmic filter criteriaPortfolio Return Report & Real-Time Stock Movement Alerts - Newser
Can ProQR Therapeutics N.V. be recession proofJuly 2025 Big Picture & Growth Focused Investment Plans - خودرو بانک
How hedge fund analytics apply to ProQR Therapeutics N.V. stockJuly 2025 Volume & Consistent Growth Equity Picks - Newser
Is ProQR Therapeutics N.V. likely to announce a buyback2025 Key Lessons & Growth Focused Stock Pick Reports - beatles.ru
Is ProQR Therapeutics N.V. stock ready for a breakoutJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
Real time breakdown of ProQR Therapeutics N.V. stock performancePortfolio Return Report & Weekly High Momentum Picks - Newser
Retinitis Pigmentosa Market to Evolve Rapidly Over the Next - openPR.com
Is ProQR Therapeutics N.V. undervalued by DCF analysisMarket Volume Report & Smart Investment Allocation Tips - خودرو بانک
Should you buy the dip on ProQR Therapeutics N.V.2025 Year in Review & Verified Momentum Stock Ideas - خودرو بانک
Candlestick signals on ProQR Therapeutics N.V. stock todayQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - Newser
Is ProQR Therapeutics N.V. a potential multi bagger2025 Macro Impact & Short-Term High Return Ideas - خودرو بانک
Momentum divergence signals in ProQR Therapeutics N.V. chartJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Can ProQR Therapeutics N.V. hit a new high this monthJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
Chart based analysis of ProQR Therapeutics N.V. trendsLong Setup & Risk Controlled Swing Alerts - Newser
Will ProQR Therapeutics N.V. benefit from current market trendsJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - khodrobank.com
Pullback Watch: Can ProQR Therapeutics N.V. be recession proofWeekly Stock Recap & Accurate Entry and Exit Point Alerts - خودرو بانک
What Fibonacci levels say about ProQR Therapeutics N.V. reboundJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - Newser
Is it too late to sell ProQR Therapeutics N.V.2025 Trade Ideas & Fast Gain Stock Tips - Newser
ProQR Therapeutics N.V. stock trend outlook and recovery pathQuarterly Profit Review & Technical Pattern Based Signals - Newser
ProQR Therapeutics N.V. recovery potential after sell off2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
Can ProQR Therapeutics N.V. recover in the next quarterJuly 2025 Trends & Low Risk Growth Stock Ideas - Newser
Buy Signal: What are ProQR Therapeutics N.V.’s recent SEC filings showingM&A Rumor & Growth Focused Investment Plans - خودرو بانک
How cyclical is ProQR Therapeutics N.V.’s revenue streamGlobal Markets & Verified Entry Point Detection - خودرو بانک
Movement Recap: Can ProQR Therapeutics N.V. be recession proofJuly 2025 Update & High Accuracy Trade Signal Alerts - خودرو بانک
Is ProQR Therapeutics N.V. benefiting from innovation trendsAnalyst Downgrade & Precise Entry and Exit Recommendations - خودرو بانک
Can ProQR Therapeutics N.V. reach resistance levels soon2025 Market Outlook & Growth-Oriented Investment Plans - خودرو بانک
What is the earnings history of ProQR Therapeutics N.V.July 2025 Rallies & Daily Profit Focused Stock Screening - خودرو بانک
Research Analysts Issue Forecasts for PRQR FY2025 Earnings - MarketBeat
Is ProQR Therapeutics N.V. building a consolidation baseMarket Growth Report & Daily Market Momentum Tracking - Newser
Proqr Therapeutics N V Azioni (PRQR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):